Last reviewed · How we verify

NCT06252090

Feasibility and Acceptability Trial of a Short Term Mentalization Based Treatment for Adolescents With Depression

Status unknown NA Last updated 9 February 2024
What this trial tests

NA trial testing Short term mentalization-based treatment for adolescents (MBT-A) in Depression in 15 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 December 2024
1 March 2025

Quick facts

Lead sponsorUniversidad de Valparaiso
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date1 September 2023
Primary completion1 December 2024
Estimated completion1 March 2025
Sites1 location across Chile

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Valparaiso — full company profile →

Who can join

Adults 10 to 14, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A feasibility pilot trial that aims to evaluate the acceptability and feasibility of mentalization-based treatment for adolescents (MBT-A) adapted for early adolescents diagnosed with depression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Universidad de Valparaiso trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06252090.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing